AJR AJR-based Continuing Ed for Technologists
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Cohen, E. G.
Right arrow Articles by Ghesani, N. V.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cohen, E. G.
Right arrow Articles by Ghesani, N. V.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
DOI:10.2214/AJR.08.1656
AJR 2009; 193:214-217
© American Roentgen Ray Society


Clinical Observations

18F-FDG PET Evaluation of Sinonasal Papilloma

Erik G. Cohen1, Soly Baredes1, Lionel S. Zuckier2, Neena M. Mirani3, Yiyan Liu2 and Nasrin V. Ghesani2

1 Department of Surgery, Division of Otolaryngology-Head and Neck Surgery, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, 140 Bergen St., Ste. E1620, Newark, NJ 07103.
2 Department of Radiology, Division of Nuclear Medicine, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ.
3 Department of Pathology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ.

Received August 11, 2008; accepted after revision September 17, 2008.

 
Address correspondence to E. G. Cohen (coheneg{at}umdnj.edu).


Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
OBJECTIVE. It has been suggested that 18F-FDG uptake determined by PET can differentiate squamous cell carcinoma from benign sinonasal papilloma. We wish to present our experience with sinonasal papillomas and PET/CT to determine if the degree of FDG uptake is indicative of benign or malignant disease.

CONCLUSION. Benign sinonasal papilloma may be associated with intense FDG uptake on PET/CT. FDG PET/CT does not appear to reliably differentiate benign from malignant sinonasal papilloma.

Keywords: FDG PET • inverted papilloma • PET/CT • sinonasal papilloma • squamous cell carcinoma


Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Sinonasal papillomas are benign tumors that occur in several histologic forms by Hyams [1] classification, including fungiform, inverted, and cylindric. Inverted papilloma is locally aggressive and has been associated with concurrent invasive squamous cell carcinoma in approximately 9% of cases [2]. Papillomas can be difficult to differentiate from squamous cell carcinoma on clinical and radiologic grounds. Preoperative imaging studies and transnasal biopsy are generally performed before definitive resection. However, squamous cell carcinoma, when present, may not involve all areas of the papilloma, making preoperative diagnosis of malignancy problematic. CT and MRI are commonly used to evaluate bone destruction and soft-tissue extension, but neither technique is useful in differentiating sinonasal papilloma from squamous cell carcinoma.

Treatment of sinonasal papillomas is primarily by complete surgical resection, most commonly either open or endoscopic medial maxillectomy. Recurrence of inverted papilloma has been reported in 18% of patients treated by standard open surgical techniques in a pooled analysis [2]. Common postsurgical follow-up consists of serial nasal endoscopy and CT or MRI. It is often difficult to differentiate postoperative mucosal thickening and fibrosis from recurrent papilloma on clinical examination and routine radiologic imaging.

Case reports of FDG uptake in several types of papillomas have been published, including tonsillar papilloma (unspecified type) [3], maxillary sinus papilloma (unspecified type) [4], pulmonary glandular papilloma [5], choroid plexus papilloma [6], and intraductal papilloma of the breast [7]. A case of inverted papilloma with intense FDG uptake (standardized uptake value [SUV], 9.0 at 1 hour and 18.1 at 2 hours) [8] and a case of sphenoid sinus oncocytic papilloma with intense uptake (mean SUV, 11.26; maximum SUV, 18.86) [9] have also been reported. Two reports have indicated that PET can be used to differentiate squamous cell carcinoma from inverted papilloma. Significantly higher FDG uptake was reported in five cases of carcinoma (SUVs, 10.40-19.3) than in five cases of sinonasal inverted papilloma (SUVs, 1.98-4.65) [10], whereas another series reported SUVs of 4.9-7.3 associated with three cases of benign inverted papilloma and higher SUVs of 8.9 and 20.9 associated with squamous cell carcinoma [11].

We performed a retrospective review of our experience with FDG PET/CT scintigraphy in the preoperative evaluation of patients with histopathology-proven sinonasal papilloma.


Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
This study was performed under an institutional review board-approved protocol. Relevant cases were identified through a search of a computerized database of patients who underwent PET/CT scintigraphy at the University of Medicine and Dentistry of New Jersey-University Hospital between April 2001 and January 2008. Medical records were retrospectively reviewed. PET/CT scans were re-reviewed by nuclear medicine physicians.

Combined PET/CT was performed using a combined PET/CT scanner (Discovery LS, GE Healthcare) and relatively standard techniques. No IV diuretics or hydration was administered, and no bladder catheterization was performed. Patients fasted for a minimum of 4 hours before PET acquisition. After confirmation of a blood glucose level < 200 mg/dL, 555 MBq (15 mCi) of sterile FDG was administered IV followed by a radiotracer uptake phase of approximately 60 minutes. Patients voided before administration of FDG and again before image acquisition. Positron emission data sets were acquired typically from the base of the skull to the mid thigh, with separate acquisition of the head and neck region from the vertex to the thoracic inlet, for 5 minutes at each bed position. PET images were reconstructed using the OSEM (ordered subset expectation maximization) algorithm. Low-dose CT was acquired and used for attenuation correction and was fused onto the PET images for anatomic correlation.


Figure 1
View larger version (114K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1A 92-year-old woman with right maxillary oncocytic papilloma. Axial contrast-enhanced CT scan shows enhancing soft-tissue lesion filling right maxillary sinus and extending into nasal cavity without bone erosion.

 


Figure 2
View larger version (159K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1B 92-year-old woman with right maxillary oncocytic papilloma. Axial T1-weighted MR image obtained with gadolinium shows enhancing soft-tissue lesion filling right maxillary sinus and extending into nasal cavity.

 


Figure 3
View larger version (94K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1C 92-year-old woman with right maxillary oncocytic papilloma. Axial FDG PET/CT fusion image (C) and PET image (D) show intense FDG uptake (mean standardized uptake value [SUV], 30.0; maximum SUV, 43.0) corresponding to right maxillary sinus soft-tissue mass.

 


Figure 4
View larger version (53K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1D 92-year-old woman with right maxillary oncocytic papilloma. Axial FDG PET/CT fusion image (C) and PET image (D) show intense FDG uptake (mean standardized uptake value [SUV], 30.0; maximum SUV, 43.0) corresponding to right maxillary sinus soft-tissue mass.

 

Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Five patients who had intranasal biopsy-proven sinonasal papilloma and had undergone FDG PET/CT examination were identified. Histopathologic evaluation after resection confirmed inverted papilloma without invasive carcinoma in four of the five cases. In the one remaining case, the final histopathologic diagnosis was oncocytic papilloma without invasive carcinoma.

Case 1
A 92-year-old woman presented with epistaxis from the right side. Her medical history was significant only for hypercholesterolemia. Physical examination revealed an exophytic lesion involving the right lateral nasal wall. The remainder of the head and neck examination was normal. Transnasal biopsy results were interpreted as inverted papilloma. A CT scan of the sinuses with IV contrast material and an MRI scan with gadolinium were obtained (Figs. 1A and 1B). A PET/CT scan revealed extremely intense FDG uptake in the right maxillary sinus and anterior ethmoid sinus, with a mean SUV of 30.0 and maximum SUV of 43.0 (Figs. 1C and 1D). The patient underwent an open medial maxillectomy.

Final pathology revealed an oncocytic papilloma (a variant of cylindric cell papilloma) with reactive atypia, without an inverted growth pattern, and with no evidence of squamous cell carcinoma.

Case 2
A 64-year-old man presented with an incidental finding of left maxillary lesion on MRI. He had a history of a cerebrovascular accident 1 year earlier. MRI of the brain at that time revealed a right transverse sinus arteriovenous malformation with an incidental finding of a maxillary sinus lesion extending into the nasopharynx (Fig. 2A). He denied any nasal obstruction, epistaxis, pain, or congestion. Physical examination of the head and neck was within normal limits. Nasal endoscopy revealed a lobulated lesion protruding from the maxillary sinus into the nasal cavity and posterior choana that was presumed to be an antrochoanal polyp. A CT scan of the sinuses was obtained (Fig. 2B). Endoscopic polypectomy was planned; however, on intraoperative examination, the lesion was not consistent with an antrochoanal polyp. Endoscopic maxillary antrostomy and partial resection for tissue diagnosis were performed.


Figure 5
View larger version (152K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2A 64-year-old man with sinonasal inverted papilloma. Axial gradient-echo T2-weighted image shows hyperintense soft-tissue mass filling left maxillary sinus and extending into nasal cavity.

 

Figure 6
View larger version (114K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2B 64-year-old man with sinonasal inverted papilloma. Axial unenhanced CT scan shows soft-tissue mass filling left maxillary sinus and extending into nasal cavity without bone erosion.

 
Final pathology was consistent with inverted papilloma with no evidence of squamous cell carcinoma. A PET/CT scan was obtained and revealed moderate FDG uptake at the posteroinferior aspect of the left maxillary sinus with a mean SUV of 2.2 and a maximum SUV of 3.5 (Figs. 2C and 2D). This area of increased uptake corresponded to the site of residual inverted papilloma, whereas the edematous mucosa anteriorly was not FDG-avid. The patient underwent an open medial maxillectomy. Final pathology revealed inverted papilloma without invasive carcinoma.


Figure 7
View larger version (128K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2C 64-year-old man with sinonasal inverted papilloma. Axial FDG PET/CT fusion image (C) and PET image (D) show residual papilloma in posterior maxillary sinus after partial excision. FDG uptake is also seen in left temporalis and longus colli muscles.

 

Figure 8
View larger version (82K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2D 64-year-old man with sinonasal inverted papilloma. Axial FDG PET/CT fusion image (C) and PET image (D) show residual papilloma in posterior maxillary sinus after partial excision. FDG uptake is also seen in left temporalis and longus colli muscles.

 

Case 3
A 52-year-old man with no significant medical or surgical history presented with complaints of progressive nasal obstruction over a 20-year period associated with rare epistaxis. Physical examination revealed a large obstructing lesion in the left nasal cavity. The remainder of the head and neck examination was normal. An intranasal biopsy specimen was consistent with inverted papilloma. A CT scan of the sinuses with IV contrast material and an MRI scan with gadolinium were obtained. A PET/CT scan revealed increased FDG uptake in the left nasal cavity that extended into the left maxillary and ethmoid sinuses and nasopharynx (mean SUV, 3.3; maximum SUV, 4.6). The uptake was heterogeneous, with more intense uptake in the maxillary sinus and nasopharynx. The patient underwent an open medial maxillectomy.

Pathology results revealed an inverted papilloma with no evidence of squamous cell carcinoma. Thickened mucosa from the lateral aspect of the maxillary sinus, sent as a separate specimen, showed respiratory epithelial adenomatoid hamartoma.

Case 4
A 47-year-old man with HIV and a 6-year history of recurrent inverted papilloma involving bilateral nasal cavities and the pharyngeal wall presented with recurrent nasal obstruction and new-onset cervical lymphadenopathy. The patient had undergone multiple previous resections at multiple institutions and had also received radiotherapy. Previous pathology results were consistent with inverted papilloma without invasive carcinoma. At the time of presentation, CT scans revealed recurrent inverted papilloma that was not completely resectable. Endoscopic partial excision of the inverted papilloma on the right and endoscopic excision of a small recurrent papilloma on the left were performed for symptomatic relief. A cervical lymph node biopsy was performed as well.

Pathology confirmed papilloma with both inverted and exophytic growth patterns without invasive carcinoma. The cervical lymph node biopsy revealed Hodgkin's lymphoma. A PET/CT scan was then obtained for lymphoma staging. Intense FDG uptake was noted in the right nasal cavity, ethmoid and maxillary sinuses, and pharynx (mean SUV, 6.2; maximum SUV, 9.0), corresponding to known areas of residual inverted papilloma.

Case 5
A 43-year-old HIV-positive man presented with a left nasal mass noted while blowing his nose, slowly growing in size. Physical examination revealed a 1-cm pedunculated lesion along the left anterior nasal septum. PET/CT scans revealed intense uptake corresponding to the nasal mass (mean SUV, 4.7; maximum SUV, 8.5). The patient underwent endoscopic excision of the mass. There was no cartilage involvement noted.

Final histopathology revealed sinonasal papilloma with both inverted and exophytic growth patterns associated with moderate to severe dysplasia involving approximately 50% of the lesion, but no invasive carcinoma.


Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
This series of cases shows significant FDG uptake on PET/CT by sinonasal papillomas. In each case, the tumor was benign with no evidence of malignant transformation. The degree of uptake in these cases varied widely, including two cases with moderate uptake, two cases with intense uptake, and one case with extremely intense uptake.

These findings suggest that although FDG PET scintigraphy may be useful in detecting sinonasal papillomas, the degree of uptake cannot be used to reliably differentiate squamous cell carcinoma from benign papilloma even when intense uptake is present. A lack of specificity of FDG uptake has been reported at several other head and neck locations. A lack of correlation of SUV with malignancy in parotid tumors has been well documented, with a similar degree of uptake reported for parotid carcinomas, Warthin tumors, and pleomorphic adenomas [12]. Similarly, investigators have reported that SUV does not correlate with malignancy in incidentally discovered thyroid lesions because 50% of nodules with focal FDG uptake are due to benign tumors or nonneoplastic conditions [13]. False-positive PET scans may also result from inflammatory conditions such as infection, granulomatous disease, asymmetric muscle activity, physiologic uptake, and inflammation and granulation at surgical sites [14, 15]. Reported causes of the reduced sensitivity of FDG PET for the detection of malignancy include partial volume averaging of small tumor volumes, non-FDG-avid tumors, and lesions occurring in areas of physiologically high FDG background [14, 15].

In this study, FDG PET scintigraphy was performed after biopsy. Biopsies performed close to the time of PET may have led to increased FDG uptake due to inflammation from the procedure. However, in this study, imaging was consistently performed more than 4 weeks after biopsy, making it unlikely that inflammation resulting from the biopsy affected the degree of uptake.

In case 1, the finding of an extremely high SUV was not associated with carcinoma. The oncocytic cells seen on routine H and E staining contained abundant mitochondria ultrastructurally, which may explain the high metabolic activity and FDG uptake. Others have attributed intense FDG uptake in inverted papilloma to the presence of marked inflammatory response within the lesion [8].

Case 2 shows the potential for the use of FDG PET scintigraphy in the postoperative setting. In this case, endoscopic partial resection was performed as a diagnostic procedure. The residual inverted papilloma had only moderate FDG uptake, but could be differentiated from adjacent edematous mucosa. Routine use of FDG PET scintigraphy in the postoperative setting cannot be recommended given its cost and radiation exposure, as well as lack of availability in some areas; however, selective use may be helpful in clinical decision making when physical examination, CT, and MRI are equivocal.

Case 3 showed heterogeneous uptake, and two separate histopathologic diagnoses were made. Most of the lesion was inverted papilloma and corresponded to the region of the most intense uptake—that is, the nasopharynx. The lateral maxillary sinus mucosa contained respiratory epithelial adenomatoid hamartoma. It is difficult to ascertain whether the uptake on PET in the maxillary sinus region was due to inverted papilloma, respiratory epithelial adenomatoid hamartoma, or both. No carcinoma was seen in any part of the specimen.

Cases 4 and 5 showed intense FDG uptake in sinonasal papillomas with both inverted and exophytic growth patterns and without invasive carcinoma. Although pathologic examination in case 5 revealed moderate to severe dysplasia, no carcinoma was seen. The degree of FDG uptake in case 5 was similar to that in case 4, which was not associated with dysplasia.

In conclusion, our findings suggest that the degree of FDG uptake on PET/CT is not a reliable indicator of malignancy associated with sinonasal papilloma because moderate to extremely intense uptake was seen with benign sinonasal papillomas. Nonetheless, FDG PET/CT scintigraphy may be useful in showing the presence and extent of sinonasal papilloma and may help in differentiating papilloma from postoperative fibrosis and mucosal edema in cases of suspected recurrent or residual papilloma.


References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 

  1. Hyams VJ. Papillomas of the nasal cavity and paranasal sinuses: a clinicopathological study of 315 cases. Ann Otol Rhinol Laryngol 1971; 80:192 -206[Medline]
  2. Krouse JH. Endoscopic treatment of inverted papilloma: safety and efficacy. Am J Otolaryngol 2001;22 : 87-99[CrossRef][Medline]
  3. Stokkel MP, Bongers V, Hordijk GJ, van Rijk PP. FDG positron emission tomography in head and neck cancer: pitfall or pathology? Clin Nucl Med 1999;24 : 950-954[CrossRef][Medline]
  4. Sakamoto H, Nakai Y, Ohashi Y, Okamura T, Ochi H. Positron emission tomographic imaging of head and neck lesions. Eur Arch Otorhinolaryngol 1997;254 [suppl 1]:S123 -S126[CrossRef][Medline]
  5. Tanaka R, Emerson LL, Karwande SV, Schreiber G. Growing pulmonary nodule with increased 18-fluorodeoxyglucose uptake in a former smoker. Chest 2005; 127:1848 -1851[CrossRef][Medline]
  6. Sunada I, Tsuyuguchi N, Hara M, Ochi H. 18F-FDG and 11C-methionine PET in choroid plexus papilloma: report of three cases. Radiat Med 2002;20 : 97-100[Medline]
  7. Nguyen BD, Lidner TK. Intraductal papilloma of the breast: F-18 FDG PET demonstration. Clin Nucl Med 2005;30 : 481-482[CrossRef][Medline]
  8. Lee KW, Kuo WR, Tsai CC, et al. Positive positron emission tomography/computed tomography in early inverted papilloma of the maxillary sinus. J Clin Oncol 2007;25 : 4848-4850[Free Full Text]
  9. Udaka T, Shiomori T, Nagatani G, et al. Oncocytic schneiderian papilloma confined to the sphenoid sinus detected by FDG-PET. Rhinology 2007;45 : 89-92[Medline]
  10. Ninomiya H, Oriuchi N, Kahn N, et al. Diagnosis of tumor in the nasal cavity and paranasal sinuses with [11C]choline PET: comparative study with 2-[18F]fluoro-2-deoxy-D-glucose (FDG) PET. Ann Nucl Med 2004;18 : 29-34[Medline]
  11. Shojaku H, Fujisaka M, Yasumura S, et al. Positron emission tomography for predicting malignancy of sinonasal IP. Clin Nucl Med 2007; 32:275 -278[CrossRef][Medline]
  12. Okamura T, Kawabe J, Koyama K, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography imaging of parotid mass lesions. Acta Otolaryngol Suppl 1998;538 : 209-213[CrossRef][Medline]
  13. Kim TY, Kim WB, Ryu JS, et al. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope 2005;115 : 1074-1078[CrossRef][Medline]
  14. Cook GJ. Pitfalls in PET/CT interpretation. Q J Nucl Med Mol Imaging 2007; 51:235 -243[Medline]
  15. Gorospe L, Raman S, Echeveste J, et al. Wholebody PET/CT: spectrum of physiological variants, artifacts and interpretative pitfalls in cancer patients. Nucl Med Commun 2005;26 : 671-687[CrossRef][Medline]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Cohen, E. G.
Right arrow Articles by Ghesani, N. V.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cohen, E. G.
Right arrow Articles by Ghesani, N. V.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS